Armistice Capital »

Rigel Pharmaceuticals shares owned by Armistice Capital

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 1.6M 8.22

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals